Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Myasthenia Gravis

Key Points about Myasthenia Gravis

  • Myasthenia gravis (MG) is a disorder that causes weakness in muscles around the body. It mostly affects the eyes, mouth, throat, arms and legs.
  • Transient neonatal MG is a temporary form of MG. It can happen in babies born to mothers with MG. The symptoms go away weeks or months after birth.
  • Juvenile MG is an autoimmune disorder. It is a lifelong condition that may go in and out of remission.
  • Congenital MG is a very rare form of MG that is inherited. Symptoms usually start at birth and are lifelong.
  • Treatment may include medicines, surgery or blood product infusions. In severe cases, a child may need a breathing machine (ventilator) to help with breathing.
  • Issues may come up as a child grows and develops. Children with MG need to see their health care team often.
  • What is myasthenia gravis?
  • What causes myasthenia gravis?
  • Who is at risk for myasthenia gravis?
  • What are the symptoms of myasthenia gravis?
  • How is myasthenia gravis diagnosed?
  • How can I help prevent myasthenia gravis?
  • How is myasthenia gravis treated?
  • What are possible complications of myasthenia gravis?
  • How can I help my child live with myasthenia gravis?
  • When should I call my child’s health care provider?
Children's Team

Children's Team


Andrea Gropman

Andrea Gropman

Division Chief, Neurodevelopmental Pediatrics and Neurogenetics
Roger Packer

Roger Packer

Senior Vice President, Center for Neuroscience and Behavioral Health
Director, Gilbert Neurofibromatosis Institute
Director, Brain Tumor Institute
Jeffrey Rabin

Jeffrey Rabin

Vice-Chair, Pediatric Rehabilitation Medicine
Pediatric Rehabilitation Specialist


Neuromuscular Medicine Program

The Neuromuscular Medicine Program leverages the expertise of a multidisciplinary teams, cutting-edge research and innovative technologies to care for a spectrum of neuromuscular conditions affecting children from infancy to age 21.


Our pediatric neuroscience team is the largest in the country, allowing us to offer our vast experience to patients and families.